Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page

9. Check if this filing amends a previously filed version of this report

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code AGR

16. Specific lobbying issues

Livestock Cloning/Product Labeling
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2011
Discussions with EU on Animal Cloning

Foreign Agriculture Biotechnology Laws and Regulations
Mexico Biotechnology Bilateral Discussions
EU Biotechnology Bilateral Discussions
APEC Agricultural Biotechnology Discussions
Discussions with EU on Animal Cloning
Vietnam Biotechnology Regulations
Turkish Biotechnology Regulations
Low-level Presence Foreign Government Policies
North America Biotechnology Initiative

World Trade Organization on EU Biotech Approvals
EU Biotechnology Negotiations

Genetically Engineered (GE) Animals
FDA Approval of First Product From GE Animals

Cartagena Biosafety Protocol
U.S. Government Positions/Activities/Communications at Biosafety Protocol Meetings

USDA/APHIS Agricultural Biotechnology Regulations
Efficient and Science-Based Review of Biotech Products
National Environmental Policy Act Requirements
Coexistence of Production Systems

U.S. Policy on Sustainable Agriculture Standard
American National Standards Institute Sustainable Agriculture Standards (ANSI)

Funding for the USDA
Agriculture, Rural Development, Food and Drug Administration, and Related Appropriations Act for FY 2011

Biomass Crop Assistance Program (BCAP)
BCAP Rulemaking and Environmental Impact Statement
2007 Farm Bill Implementation

U.S. Government Agriculture Research Funding
Agriculture, Rural Development, Food and Drug Administration, and Related Appropriations Act for FY 2011

Global Food Security Initiative
U.S. Government Strategy
Funding
Department of State, Foreign Operations and Related Programs Appropriations Act for FY 2011

EPA Regulations on Agricultural Biotechnology
Insect Resistance Management
FIFRA Section 7 Regulations
Implementation of Pesticide Registration Improvement Act

Biotechnology Stewardship
Biotech Quality Management Stewardship Program

Food and Agriculture Organization Biotechnology Initiatives
USG Position on FAO Biotechnology Conference

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Agriculture - Dept of (USDA), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), State - Dept of (DOS), U.S. Trade Representative (USTR), Office of Science & Technology Policy (OSTP), Office of Management & Budget (OMB), Commerce - Dept of (DOC)

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code ANI

16. Specific lobbying issues

Genetically Engineered (GE) Animals
FDA Approval of First Product From GE Animals

Livestock Cloning/Product Labeling
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2011
Discussions with EU on Animal Cloning

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Agriculture - Dept of (USDA), Food & Drug Administration (FDA), Office of Science & Technology Policy (OSTP), U.S. Trade Representative (USTR), Office of Management & Budget (OMB),

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code BUD

16. Specific lobbying issues

Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2011
Funding for the Food and Drug Administration (Human Drug Review, Biologics, Food Safety, Critical Path, Reagan-Udall
Foundation, Center for Veterinary Medicine, Scientific Infrastructure)
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2011 Cont...
Funding for the USDA (Office of General Counsel, Biotechnology Regulatory Service (APHIS), Animal Care & Veterinary
Services (APHIS), Trade Activities (Office of the Secretary & Food Safety Inspection Service), Agriculture Research
Service, Biofuels, Foreign Agricultural Service)
Livestock Cloning/Product Labeling
Funding for Biofuels and Bio-based Products
Drug Importation

Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2011
Funding for National Institutes of Health
Cures Acceleration Network
Funding for Bioterrorism and Emergency Preparedness
Funding for Pandemic Influenza Preparedness
Funding for Biomedical Advanced Research and Development Authority (BARDA)
Funding for Centers for Disease Control and Prevention Vaccine Programs
Funding for Strategic National Stockpile
Drug Importation

Energy and Water Development and Related Agencies Appropriations Act for FY 2011
Funding for Biofuels and Bio-based Products
Biorefineries
Funding for Reverse Auction Loan Program under Section 942 of the Energy Policy Act of 2005

Department of State, Foreign Operations and Related Programs Appropriations Act for FY 2011
Funding for Biotechnology Research and Development Programs at the Agency for International Development and
Department of State
Funding for Global Food Security Initiative
Funding for the Bureau of Economic, Energy, and Business Affairs (EEB) at the Department of State

Department of Homeland Security Appropriations Act for FY 2011
Drug Importation

Budget of the United States for FY 2011
Funding for Biofuels and Bio-based Products

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, White House Office

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code CAW

16. Specific lobbying issues

Climate Change Benefits of Biofuels and Bio-based Products
H.R. 2454: American Clean Energy and Security Act of 2009
Bio-based Product Tax Credit
Senate Climate Change Discussion Draft (Sen. Kerry, Graham & Lieberman)
IP Rights for Environmental Technologies
U.S. Government Position for U.N. Convention on Climate Change Negotiations

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, State - Dept of (DOS), U.S. Trade Representative (USTR),

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code CPT

16. Specific lobbying issues

Patent Reform
H.R. 1260: The Patent Reform Act of 2009
S. 515. The Patent Reform Act of 2009
S.610: The Patent Reform Act of 2009
World Trade Organization Special 301 Submissions

Convention on Biological Diversity Patent Disclosure Requirements

Gene Patenting
Possible Legislation by Rep. Wasserman Schultz
Genomic Research and Accessibility Act (Discussion Draft)
Bayh-Dole Act/Tech Transfer
HHS Secretary's Advisory Committee Report

IP Rights for Environmental Technologies
U.S. Government Position for U.N. Convention on Climate Change Negotiations

PTO Administrative Reforms

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, State - Dept of (DOS), U.S. Trade Representative (USTR), Patent & Trademark Office (PTO), Commerce - Dept of (DOC), Health & Human Services - Dept of (HHS)

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code CSP

16. Specific lobbying issues

Genetically Engineered (GE) Animals
FDA Approval of First Product From GE Animals

Drug Importation
H.R. 3590: (Senate) Patient Protection and Affordable Care Act
S. 1796: America's Healthy Future Act of 2009
H.R. 4872: Health Care and Education Reconciliation Act of 2011
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2011
Department of Homeland Security Appropriations Act for FY 2011
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2011

Funding for the Food and Drug Administration
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2011

Reporting of Physician Payments
S.310: Physician Payments Sunshine Act of 2009
H.R. 3590: (Senate) Patient Protection and Affordable Care Act
S. 1796: America's Healthy Future Act of 2009
S.1679: Affordable Health Choices Act of 2009

Livestock Cloning/Product Labeling
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2011
Discussion with EU on Animal Cloning

USDA/APHIS Agricultural Biotechnology Regulations
Efficient & Science-Based Review of Biotech Products
National Environmental Policy Act Requirements
Coexistence of Production Systems

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Agriculture - Dept of (USDA), Food & Drug Administration (FDA), U.S. Trade Representative (USTR), Office of Science & Technology Policy (OSTP), Office of Management & Budget (OMB), Environmental Protection Agency (EPA), State - Dept of (DOS)

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code ENG

16. Specific lobbying issues

Renewable Fuels Standard
EPA Rulemaking on Life-cycle Greenhouse Gas Emissions Requirements
Implementation of Energy Independence and Security Act of 2007
Regulatory Oversight
Algae-based Renewable Fuel/Carbon Capture and Conversion
S.1250: Algae-based Renewable Fuel Promotion Act of 2009
H.R. 4168: Algae-based Renewable Fuel Promotion Act of 2009
Biofuels Production Tax Credit Modification for Algae-based Biofuels

Biofuels
Funding
Budget of the United States for FY 2011
Energy and Water Development and Related Agencies Appropriations Act for FY 2011
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2011
DOE Loan Guarantees and Grants under The Energy Policy Act of 2005 (Implementation and Funding)
USDA Loan Guarantees and Grants under The Food Conservative & Energy Act of 2008 (Implementation and Funding)
Economic Growth Impact/Potential of Advanced Biofuels
Next Generation Incentives
Farm Bill Reauthorization
Biofuels Production Tax Credit Extension

Bio-based Products
Tax Credit
Funding
Budget of the United States for FY 2011
Energy and Water Development and Related Agencies Appropriations Act for FY 2011
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2011
Economic Growth Impact/Potential

Climate Change Benefits of Biofuels and Bio-based Products
H.R. 2454: American Clean Energy and Security Act of 2009
Bio-based Product Tax Credit
Senate Climate Change Discussion Draft (Sen. Kerry, Graham & Lieberman)

Biorefineries
Next Generation Tax Credits
Modification of the Advanced Energy Products Tax Credit
Funding for Reverse Auction Loan Program under Section 942 of the Energy Policy Act of 2005
Energy and Water Development and Related Agencies Appropriations Act for FY 2011

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Agriculture - Dept of (USDA), Environmental Protection Agency (EPA), White House Office, Treasury - Dept of,

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code FOO

16. Specific lobbying issues

Genetically Engineered (GE) Animals
FDA Approval of First Product From GE Animals

Livestock Cloning/Product Labeling
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2011
Discussion with EU on Animal Cloning

Global Food Security Initiative
U.S. Government Strategy
Funding
Departments of State, Foreign Operations and Related Programs Appropriations Act for FY 2011

USDA/APHIS Agricultural Biotechnology Regulations
Efficient and Science-Based Review of Biotech Products
National Environmental Policy Act Requirements
Coexistence of Production Systems

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Agriculture - Dept of (USDA), Food & Drug Administration (FDA), U.S. Trade Representative (USTR), Office of Science & Technology Policy (OSTP), State - Dept of (DOS), Office of Management & Budget (OMB), Environmental Protection Agency (EPA)

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code FUE

16. Specific lobbying issues

Renewable Fuels Standard
EPA Rulemaking on Life-cycle Greenhouse Gas Emissions Requirements
Implementation of Energy Independence and Security Act of 2007
Regulatory Oversight
Algae-based Renewable Fuel/Carbon Capture and Conversion
S.1250: Algae-based Renewable Fuel Promotion Act of 2009
H.R. 4168: Algae-based Renewable Fuel Promotion Act of 2009
Biofuels Production Tax Credit Modification for Algae-based Biofuels

Biofuels
Funding
Budget of the United States for FY 2011
Energy and Water Development and Related Agencies Appropriations Act for FY 2011
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2011
DOE Loan Guarantees and Grants under The Energy Policy Act of 2005 (Implementation and Funding)
USDA Loan Guarantees and Grants under The Food Conservative & Energy Act of 2008 (Implementation and Funding)
Economic Growth Impact/Potential of Advanced Biofuels
Next Generation Incentives
Farm Bill Reauthorization
Biofuels Production Tax Credit Extension

Bio-based Products
Tax Credit
Funding
Budget of the United States for FY 2011
Energy and Water Development and Related Agencies Appropriations Act for FY 2011
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2011
Economic Growth Impact/Potential

Climate Change Benefits of Biofuels and Bio-based Products
H.R. 2454: American Clean Energy and Security Act of 2009
Bio-based Product Tax Credit
Senate Climate Change Discussion Draft (Sen. Kerry, Graham & Lieberman)

Biorefineries
Next Generation Tax Credits
Modification of the Advanced Energy Products Tax Credit
Funding for Reverse Auction Loan Program under Section 942 of the Energy Policy Act of 2005
Energy and Water Development and Related Agencies Appropriations Act for FY 2011

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Environmental Protection Agency (EPA), Agriculture - Dept of (USDA),

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code HCR

16. Specific lobbying issues

Healthcare Reform
Comparative Effectiveness Research Program Initiatives
Vaccine Access/Financing
Health Care Reform Cont...
Follow-on Biologics
Reporting of Physician Payments
Expansion of 340B Drug Pricing Program
Generic Fill Incentives
Therapeutic Discovery Project Tax Credit
Pharmaceutical Fee
Medicaid Rebates
Drug Importation
Cures Acceleration Network
Medicare Prescription Drug Coverage
H.R. 3590: (Senate) Patient Protection and Affordable Care Act
H.R. 3962: Affordable Health Care for America Act
S. 1679: Affordable Health Choices Act of 2009
H.R. 4872: Health Care and Education Reconciliation Act of 2010

Drug Importation
H.R. 3590: (Senate) Patient Protection and Affordable Care Act
S.1796: America's Healthy Future Act of 2009
H.R. 4872: Health Care and Education Reconciliation Act of 2011
Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations for FY 2011
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2011
Department of Homeland Security Appropriations Act for FY 2011

Funding for the Food and Drug Administration
Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations for FY 2011

Stem Cell Research

Medicaid Rebates
S.1796: America's Healthy Future Act of 2009
H.R. 3590: (Senate) Patient Protection and Affordable Care Act
H.R. 3962: Affordable Health Care for America Act
H.R. 4872: Health Care and Education Reconciliation Act of 2010

Generic Fill Incentives
H.R. 3590: (Senate) Patient Protection and Affordable Care Act
H.R. 3962: Affordable Health Care for America Act

Medicare Prescription Drug Coverage
H.R. 3590: (Senate) Patient Protection and Affordable Care Act

Follow-on Biologics
Reimbursement Issues
S.1679: Affordable Health Choices Act of 2009
S.1796: America's Healthy Future Act of 2009
H.R. 3590: (Senate) Patient Protection and Affordable Care Act
H.R. 3962: Affordable Health Care for America Act
H.R. 4872: Health Care and Education Reconciliation Act of 2010


Funding for Biomedical Advanced Research & Development Authority (BARDA)
Departments of Labor, Health and Human Services and Education, and Related Agencies Appropriations Act for FY 2011

Comparative Effectiveness Program Initiatives
H.R. 2502: Comparative Effectiveness Research Act of 2009
S.1213: Patient-Centered Outcomes Research Act of 2009
S.1796: American's Health Future Act of 2009
S.1679: Affordable Health Choices Act of 2009
H.R. 3590: (Senate) Patient Protection and Affordable Care Act
H.R. 3962: Affordable Health Care for America Act

Funding for National Institutes of Health
Departments of Labor, Health and Human Services and Education, and Related Agencies Appropriations Act for FY 2011
Cures Acceleration Network

Funding for Bioterrorism and Emergency Preparedness
Departments of Labor, Health and Human Services and Education, and Related Agencies Appropriations Act for FY 2011

Funding for Pandemic Influenza Preparedness
Departments of Labor, Health and Human Services and Education, and Related Agencies Appropriations Act for FY 2011

Funding for Centers for Disease Control and Prevention Vaccine Programs
Departments of Labor, Health and Human Services and Education, and Related Agencies Appropriations Act for FY 2011

Funding for Strategic National Stockpile
Departments of Labor, Health and Human Services and Education, and Related Agencies Appropriations Act for FY 2011

Reporting of Physician Payments
S. 310: Physician Payments Sunshine Act of 2009
H.R. 3590: (Senate) Patient Protection and Affordable Care Act
S.1796: American's Health Future Act of 2009
S.1679: Affordable Health Choices Act of 2009

Vaccine Access/Financing
S.1796:America's Healthy Future Act of 2009
S.1679: America's Affordable Health Choices Act of 2009
H.R. 3590: (Senate) Patient Protection and Affordable Care Act
S. 2868: Federal Supply Schedules Usage Act of 2009
S.1649: Weapons of Mass Destruction Preparedness Act of 2009
H.R. 4872: Health Care and Education Reconciliation Act of 2010

Expansion of 340B Drug Pricing Program
S.1796:America's Healthy Future Act of 2009
H.R. 3590: (Senate) Patient Protection and Affordable Care Act
H.R. 3962: Affordable Health Care for America Act
H.R. 4872: Health Care and Education Reconciliation Act of 2010

Expanded Access to Experimental Products
FDA Rules
Development of Medical Countermeasures in Response to Bio-threats
HHS Countermeasures Review

Cures Acceleration Network
H.R. 3590: (Senate) Patient Protection and Affordable Care Act
Funding
Departments of Labor, Health and Human Services and Education, and Related Agencies Appropriations Act for FY 2011

Alliance for Healthcare Competitiveness

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Food & Drug Administration (FDA), Treasury - Dept of, Health & Human Services - Dept of (HHS), Natl Institutes of Health (NIH), Natl Security Council (NSC), Centers For Disease Control & Prevention (CDC), U.S. Trade Representative (USTR)

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code HOM

16. Specific lobbying issues

Funding for Pandemic Influenza Preparedness
Departments of Labor, Health and Human Services and Education, and Related Agencies Appropriations Act for FY 2011

Funding for Biomedical Advanced Research & Development Authority (BARDA)
Departments of Labor, Health and Human Services and Education, and Related Agencies Appropriations Act for FY 2011

Funding for Bioterrorism and Emergency Preparedness
Departments of Labor, Health and Human Services and Education, and Related Agencies Appropriations Act for FY 2011

Development of Medical Countermeasures in Response to Bio-threats
HHS Countermeasures Review

Funding for Strategic National Stockpile
Departments of Labor, Health and Human Services and Education, and Related Agencies Appropriations Act for FY 2011

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Natl Security Council (NSC), Health & Human Services - Dept of (HHS), Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA),

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code MED

16. Specific lobbying issues

Funding for Bioterrorism and Emergency Preparedness
Departments of Labor, Health and Human Services and Education, and Related Agencies Appropriations Act for FY 2011

Funding for National Institutes of Health
Departments of Labor, Health and Human Services and Education, and Related Agencies Appropriations Act for FY 2011
Cures Acceleration Network

Funding for Biomedical Advanced Research & Development Authority (BARDA)
Departments of Labor, Health and Human Services and Education, and Related Agencies Appropriations Act for FY 2011

Funding for the Food and Drug Administration
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2011

Funding for Pandemic Influenza Preparedness
Departments of Labor, Health and Human Services and Education, and Related Agencies Appropriations Act for FY 2011

Stem Cell Research

Comparative Effectiveness Program Initiatives
H.R. 2502: Comparative Effectiveness Research Act of 2009
S.1213: Patient-Centered Outcomes Research Act of 2009
S.1796: American's Health Future Act of 2009
S.1679: Affordable Health Choices Act of 2009
H.R. 3590: (Senate) Patient Protection and Affordable Care Act
H.R. 3962: Affordable Health Care for America Act

Cures Acceleration Network
H.R. 3590: (Senate) Patient Protection and Affordable Care Act
Funding
Departments of Labor, Health and Human Services and Education, and Related Agencies Appropriations Act for FY 2011

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Health & Human Services - Dept of (HHS), Natl Institutes of Health (NIH),

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code MMM

16. Specific lobbying issues

Medicaid Rebates
S.1796: America's Healthy Future Act of 2009
H.R. 3590: (Senate) Patient Protection and Affordable Care Act
H.R. 3962: Affordable Health Care for America Act
Medicaid Rebates Cont.
H.R. 4872: Health Care and Education Reconciliation Act of 2010

Reimbursement for Follow-on Biologics
H.R. 3590: (Senate) Patient Protection and Affordable Care Act
S.1796: America's Healthy Future Act of 2009
H.R. 4872: Health Care and Education Reconciliation Act of 2010
S.1679: Affordable Health Choices Act of 2009

Medicare Prescription Drug Coverage
H.R. 3590: (Senate) Patient Protection and Affordable Care Act

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code SCI

16. Specific lobbying issues

Small Business Innovation and Research (SBIR) Program Reauthorization
H.R. 2965/S.1233: Enhancing Small Business Research and Innovation Act of 2009

Stem Cell Research
Research & Development Tax Credit Extension
H.R. 4213: Tax Extenders Act of 2009

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Small Business Adminstration (SBA),

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code SMB

16. Specific lobbying issues

Small Business Innovation and Research (SBIR) Program Reauthorization
H.R. 2965/S.1233: Enhancing Small Business Research and Innovation Act of 2009

Therapeutic Discovery Project Tax Credit
S.1796: America's Healthy Future Act of 2009
H.R. 3590: (Senate) Patient Protection and Affordable Care Act
H.R. 3962: Affordable Health Care for America Act
H.R. 4872: Health Care and Education Reconciliation Act of 2010

Sarbanes Oxley Section 404 (b) Exemption
H.R. 4173: Wall Street Reform and Consumer Protection Act of 2009
Senate Financial Regulatory Reform Discussion Draft

Modifications to Internal Revenue Code Section 1202 for Qualified Small Business Stock Incentive

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Small Business Adminstration (SBA), Treasury - Dept of,

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code TAX

16. Specific lobbying issues

Therapeutic Discovery Project Tax Credit
S.1796: America's Healthy Future Act of 2009
H.R. 3590: (Senate) Patient Protection and Affordable Care Act
H.R. 3962: Affordable Health Care for America Act
Therapeutic Discovery Project Tax Credit Cont...
H.R. 4872: Health Care and Education Reconciliation Act of 2010

Bio-based Products
Tax Credits

Pharmaceutical Fee
S.1796: America's Healthy Future Act of 2009
H.R. 3590: (Senate) Patient Protection and Affordable Care Act

Research and Development Tax Credit Extension
H.R. 4213: Tax Extenders Act of 2009

Biofuels Production Tax Credit Modification for Algae-based Biofuels
S.1250: Algae-based Renewable Fuel Promotion Act of 2009
H.R. 4168: Algae-based Renewable Fuel Promotion Act of 2009

Election of R&D/AMT Tax Credits in Lieu of Bonus Depreciation

Modification to Internal Revenue Code Section 1202 for Qualified Small Business Stock Incentive

Biofuels Production Tax Credit Extension

Biorefineries
Next Generation Tax Credits
Modifications to the Advanced Energy Products Tax Credits

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Treasury - Dept of

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code TRD

16. Specific lobbying issues

Cartagena Biosafety Protocol
U.S. Government Positions/Activities/Communications at Biosafety Protocol Meetings

Foreign Agriculture Biotechnology Laws and Regulations
Mexico Biotechnology Bilateral Discussions
EU Biotechnology Bilateral Discussions
APEC Agricultural Biotechnology Discussions
Discussions with EU on Animal Cloning
Vietnam Biotechnology Regulations
Turkish Biotechnology Regulations
Low-level Presence Foreign Government Policies
North America Biotechnology Initiative

World Trade Organization Special 301 Submissions

World Trade Organization on EU Biotech Approvals
EU Biotechnology Negotiations

Drug Importation
H.R. 3590: (Senate) Patient Protection and Affordable Care Act
S.1796: America's Health Future Act of 2009
H.R. 4872: Health Care and Education Reconciliation Act of 2010
Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations for FY 2011
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2011
Department of Homeland Security Appropriations Act for FY 2011

Livestock Cloning/Product Labeling
Discussion with EU on Animal Cloning

Alliance for Healthcare Competitiveness

Funding for International Trade Activities at the USDA (Office of the Secretary & Food Safety Inspection Service, Foreign Agricultural Service)
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2011

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Agriculture - Dept of (USDA), State - Dept of (DOS), U.S. Trade Representative (USTR),

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code PHA

16. Specific lobbying issues

Medicaid Rebates
S.1796: America's Healthy Future Act of 2009
H.R. 3590: (Senate) Patient Protection and Affordable Care Act
H.R. 3962: Affordable Health Care for America Act
Medicaid Rebates Cont...
H.R. 4872: Health Care and Education Reconciliation Act of 2010

Comparative Effectiveness Program Initiatives
H.R. 2502: Comparative Effectiveness Research Act of 2009
S.1213: Patient-Centered Outcomes Research Act of 2009
S.1796: American's Health Future Act of 2009
S.1679: Affordable Health Choices Act of 2009
H.R. 3590: (Senate) Patient Protection and Affordable Care Act
H.R. 3962: Affordable Health Care for America Act

Medicare Prescription Drug Coverage
H.R. 3590: (Senate) Patient Protection and Affordable Care Act

Generic Fill Incentives
H.R. 3590: (Senate) Patient Protection and Affordable Care Act
H.R. 3962: Affordable Health Care for America Act

Drug Importation
H.R. 3590: (Senate) Patient Protection and Affordable Care Act
S.1796: America's Healthy Future Act of 2009
H.R. 4872: Health Care and Education Reconciliation Act of 2010
Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations for FY 2011
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2011
Department of Homeland Security Appropriations Act for FY 2011

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Health & Human Services - Dept of (HHS),

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

Information Update Page - Complete ONLY where registration information has changed.

20. Client new address

21. Client new principal place of business (if different than line 20)

22. New General description of client’s business or activities

LOBBYIST UPDATE

23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client

ISSUE UPDATE

24. General lobbying issue that no longer pertains

AFFILIATED ORGANIZATIONS

25. Add the following affiliated organization(s)

Internet Address: BIO maintains a list of all of its members on its website at http://bio.org/membership/index.asp

26. Name of each previously reported organization that is no longer affiliated with the registrant or client

FOREIGN ENTITIES

27. Add the following foreign entities:

28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization